Category Archives: Chantix

Featured Stories
Whistleblower Wins Retaliation - Canaveral National Seashore

Whistleblower Wins Retaliation Lawsuit

A whistleblower who reported misconduct at Canaveral National Seashore has won a retaliation ruling against the U.S. Department of Interior, Florida Today reports.

Read More

First Bard Avaulta Transvaginal Mesh Lawsuit Scheduled for February Trial in MDL

The first test trials in the federal C.R. Bard Avaulta transvaginal mesh litigation will most likely start next year, according to a report from Bloomberg News. About 600 lawsuits involving Bard Avaulta transvaginal mesh products are currently pending in the multidistrict litigation underway Charleston, West Virginia. U.S. District Judge Joseph ...

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

System for Tracking Prescription Drug Side Effects Flawed

Study Finds System for Tracking Prescription Drug Side Effects Flawed

System for keeping track of dangerous side effects of prescription drugs is flawed because drug makers are submitting incomplete information about problems to the FDA.

Read More

Cancer Groups Call for E-cigarettes Regulation/Research

Two-Leading-Cancer-Groups-Issue-Call-for-Regulation-of-E-cigarettes-and-Research-on-Health-Risks

The American Society of Clinical Oncology & the American Association for Cancer Research called for government regulation & research of e-cigarettes on health effects.

Read More

British Health Agency Strengthens Warnings about Valproate

British Health Agency Strengthens Warnings about Valproate Risk in Pregnancy

Statement issued urging healthcare professionals to give women information on birth defects when Depakote and other valproate medicines are used during pregnancy.

Read More

Do Vitamin Drinks Pose Health Risks?Do Vitamin Drinks Pose Health Risks?

Do Vitamin Drinks Pose Health Risks?

Scientists are concerned vitamin drinks are contributing to levels of vitamins and other nutrients that are not only unnecessary, but potentially harmful.

Read More

Transvaginal Mesh a Nightmare for Thousands of Women

Thousands of women who have received transvaginal mesh surgical implants to treat stress urinary incontinence (SUI) and pelvic organ prolapse (POP) are now living a nightmare, thanks to debilitating pain, bleeding, infection and other serious complications. According to the Sun-Sentinel, many of the women injured by transvaginal mesh claim ...

Read More

FDA Metal-On-Metal Hip Replacement Investigation Is Flawed, Researchers Say

The U.S. Food & Drug Administration’s (FDA) metal-on-metal hip replacement investigation is flawed, according to researchers.

Read More

FDA Advisory Panel Wrestling with Metal-on-Metal Hip Replacement Safety

An advisory panel for the U.S. Food & Drug Administration (FDA) began a highly-anticipated meeting yesterday to discuss the safety of metal-on-metal hip implants. Among other things, the panel of outside experts is being asked to make recommendations regarding the best practices for monitoring patients with metal-on-metal hip replacements. ...

Read More

FDA Scrutinizes Pfizer Study Evaluating Chantix Suicide Risks

FDA Scrutinizes Pfizer Study Detailing Chantix Suicide Risks

The U.S. Food and Drug Administration (FDA) is questioning whether or not Pfizer’s study of neuropsychiatric effects of Chantix, the smoking cessation drug, accurately reflects the risks. Pfizer conducted the clinical trial upon request from the FDA, following a high … Continue reading

Posted in Chantix, Pharmaceuticals | Tagged , , , , , , , |

Expert Witness in Chantix Case Seeks Pfizer Documents

An expert witness in the multidistrict litigation over Chantix (varenicline), a smoking cessation drug, has moved to unseal court records in advance of a Food and Drug Administration (FDA) meeting to consider whether the drug should carry a warning about … Continue reading

Posted in Chantix, Pharmaceuticals |

FDA to Convene Panel on Smoking Cessation Drug, Chantix, Over Psychiatric, Behavioral Side Effect Risks

The U.S. Food and Drug Administration (FDA) announced that it plans to review Chantix, the smoking cessation drug, to determine if its quit smoking benefits exceed its psychiatric and behavioral risks, Approved in 2006, Chantix received the U.S. Food and … Continue reading

Posted in Chantix, Pharmaceuticals |

Motion denied to delay Chantix trial

The first trial alleging the stop-smoking drug Chantix causes serious and some life-threatening side effects will go forward as scheduled after a federal court judge denied a request by the drug’s maker to delay it in light of a new … Continue reading

Posted in Chantix, Health Concerns, Pharmaceuticals | Tagged |

BPA Side Effects May Be Long Lasting

A recent study suggests that the side effects of BPA may be long lasting. BPA, or bisphonel A, a controversial plastics chemical, has been linked to a growing and broad array of adverse health effects. In this study, the effects … Continue reading

Posted in Chantix, Legal News, Radiation Exposure Environmental Contamination |

U. Of Penn Researchers Testing Chantix Despite Risks

Despite its known risks, University of Pennsylvania researchers plan on testing the smoking cessation medication, Chantix (varenicline). The U.S. Food & Drug Administration (FDA) approved Chantix in 2006. Chantix blocks nicotine by targeting the brain’s nicotine receptors; however, about a … Continue reading

Posted in Chantix, Health Concerns, Pharmaceuticals |

Study Finds Chantix Linked to Suicidal Behavior, Depression More Frequently than Other Stop-Smoking Treatments

A team of researchers is calling on the U.S. Food & Drug Administration (FDA) to beef up warnings for < "http://www.yourlawyer.com/topics/overview/chantix_side_effects">Chantix (varenicline), after their study found the drug’s psychological side effects make it unsuitable for first-line use as a smoking-cessation … Continue reading

Posted in Chantix, Pharmaceuticals |

FDA Modifies Chantix Label for Heart, COPD Patients

The < "http://www.yourlawyer.com/topics/overview/chantix_side_effects">Chantix label has been updated with new information regarding the safety and efficacy of the smoking cessation medication, according to an announcement from the U.S. Food & Drug Administration (FDA). The modifications to the Chantix label apply to … Continue reading

Posted in Chantix, Pharmaceuticals |

Chantix Study Sees Significant Increase in Heart Risks

People taking < "http://www.yourlawyer.com/topics/overview/chantix_side_effects">Chantix (varenicline), Pfizer Inc.’s controversial stop-smoking drug, face a much higher risk of heart attacks, strokes and other serious cardiovascular events, according to a new study from researchers at Johns Hopkins University and Wake Forest Baptist Medical … Continue reading

Posted in Chantix, Pharmaceuticals |

Health Canada Reviewing Champix for Heart Side Effects

Health Canada is reviewing the smoking cessation drug Champix (sold as < "http://www.yourlawyer.com/topics/overview/chantix_side_effects">Chantix is the U.S.) for a possible link to heart problems. The Health Canada announcement follows last week’s notification by the U.S. Food & Drug Administration (FDA) that … Continue reading

Posted in Chantix, Pharmaceuticals |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.